BaseSpace
Import Your Data
QuickView

FAQ

More QuickView FAQs

Back to top
Clear Search sequence regions
(e.g. Influenza, Intestine, Hematopoietic cell, Doxorubicin, rs7903146, FXYD4)
Bookmark Forward

QuickView for PARP (gene)


Body Atlas

Most Correlated Tissues

  1. B lymphocyte (IgM memory) of spleen
  2. B lymphocyte (naive) of spleen
  3. Plasma cell of spleen
  4. Tonsil
  5. Olfactory bulb
Explore Body Atlas Results

Disease Atlas

Most Correlated Diseases

  1. Xeroderma pigmentosum
  2. Sepsis due to Streptococcus agalactiae
  3. Systemic infection
  4. Smoker
  5. COVID-19
Explore Disease Atlas Results

Pharmaco Atlas

Most Correlated Compounds

  1. 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine
  2. Aminoglutethimide
  3. 5-(6)-carboxyfluorescein diacetate succinimidyl ester
  4. Ethylene Glycol
  5. Dipyrone
Explore Pharmaco Atlas Results

Knockdown Atlas

Most Correlated Gene Perturbations

  1. Mir129
  2. Zfp281
  3. FOSL2
  4. PARP1
  5. unc-13
Explore Knockdown Atlas Results

Curated Studies

Most Correlated Studies

Loading...
Explore Curated Studies Results

Literature

Most Relevant Literature

  1. PARP1 Promotes Heart Regeneration and Cardiomyocyte Proliferation.
  2. Adaptive genetic mechanisms in mammalian Parp1 locus.
  3. siRNA targeting PARP-1 alleviates diabetic peripheral neuropathy in a streptozotocin-induced rat mod…
  4. DEF6 regulates renal ischemia reperfusion injury through suppressing the WWP2 mediated ubiquitinatio…
  5. The luciferase-based in vivo protein-protein interaction assay revealed that CHK1 promotes PP2A and …
Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

  1. The Clinical Markers for PARP Inhibitors-related Efficacy in Ovarian Cancer
  2. PD1 and PARP for Maintenance Therapy in NSLLC
  3. Effect of PARP Inhibitors on Glomerular Filtration Rate
  4. PARP Inhibitor BMN-673 and Temozolomide or Irinotecan Hydrochloride in Treating Patients With Locall…
  5. REVITALIZE: RCT to Reduce Fatigue in Adults With Ovarian Cancer on PARP Inhibitors
Explore Clinical Trials Results
  • Copyright © 2024 Illumina Inc. All rights reserved.